Skip to main content
. 2024 Mar 28;7(3):e244294. doi: 10.1001/jamanetworkopen.2024.4294

Table 1. Sociodemographic and Clinical Characteristics.

Characteristics Patients, No. (%)
Not immunosuppressed (n = 72) Immunosuppressed (n = 43) Total (N = 115)
Age, mean (SD), y 63 (17) 65 (14) 64 (16)
Sex
Male 49 (68) 26 (60) 75 (66)
Female 23 (32) 17 (40) 39 (34)
Season of presentation
Summer 36 (50) 20 (47) 56 (49)
Fall 34 (47) 22 (51) 56 (49)
Duration of symptoms, median (IQR), d [No. missing] 5 (3-7) [1] 7 (4-14) [3] 6 (3-9) [4]
Symptoms and signs
Malaise 55 (76) 28 (65) 83 (72)
Fever 50 (70) 26 (61) 76 (66)
Headache 45 (63) 18 (42) 63 (55)
Altered mental status 41 (57) 33 (77) 74 (64)
Diarrhea or vomiting [No. missing] 33 (47) [1] 21 (49) [0] 54 (48) [1]
Myalgias 32 (44) 9 (21) 41 (36)
Hand tremors 24 (33) 13 (30) 37 (32)
Skin rash 17 (24) 10 (23) 27 (24)
Focal motor signs [No. missing] 12 (17) [1] 13 (30) [0] 25 (22) [1]
Cranial nerve signs 5 (7) 6 (14) 11 (10)
Myoclonus 3 (4) 8 (19) 11 (10)
Clinical seizure 4 (8) 6 (19) 10 (12)
Coma (GCS<8) 14 (19) 15 (35) 29 (25)
WNV-specific laboratory findings [No. missing]
Serum WNV IgM, positive 61 (78) [5] 33 (81) [2] 94 (87) [7]
CSF WNV IgM, positive 47 (78) [12] 24 (62) [4] 71 (72) [16]
CSF WNV PCR, positive 5 (15) [39] 17 (63) [16] 22 (37) [55]
CSF WBC count, median (IQR), /μL 113 (62-355) [7] 79 (20-144) [5] 90 (41-229) [12]
CSF protein, median (IQR), mg/dL 86 (65-104) [8] 75 (52-99) [6] 82 (61-101) [14]
CSF glucose, median (IQR), mg/dL 59 (53-72) [7] 64 (57-72) [8] 61 (54-72) [15]
Final diagnosis
WNV meningoencephalitis 65 (90) 33 (77) 98 (85)
WNV encephalomyelitis 3 (4) 7 (16) 10 (9)
WNV myeloradiculitis 4 (6) 3 (7) 7 (6)

Abbreviations: CSF, cerebrospinal fluid; GCS, Glasgow Coma Scale; IgM, immunoglobulin M; PCR, polymerase chain reaction; WBC, white blood cell; WNV, West Nile virus.

SI conversion factor: To convert WBC to ×109/L, multiply by 0.001.